301333 R&G PharmaStudies
- 43.77
- -0.41-0.93%
R&G PharmaStudies News
R&G PharmaStudies: Announcement on the progress of joint investment and establishment of industrial funds and related transactions with professional institutions
R&G PharmaStudies: China International Finance Corporation's 2023 Follow-up Report on Norske (Beijing) Pharmaceutical Technology Co., Ltd.
Norsk: 301333 Norsk research activity information 20240423
Norsk: Rules of work for the Board of Directors Audit Committee
Norske: Annual Report 2023
Norske: 2023 Independent Director Debriefing Report (Lan Lipeng)
Norsk: Announcement on the use of some idle funds raised and own funds for cash management
Norsk: external guarantee system
Norske: Independent Director Nominee's Statement and Commitment (Sun Wen)
Norske: 2023 Independent Director Debriefing Report (Han Hui)
Norske: Announcement on the election of the Board of Directors for a new term
Norske: Independent Director Nominee's Statement and Commitment (Li Feng)
Norske: China International Finance Corporation's verification opinion on the storage and actual use of funds raised by Norske (Beijing) Pharmaceutical Technology Co., Ltd. in 2023
Norsk: Related Transaction Management System
Norske: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Northgard: Supervisory Board Resolutions Announcement
Norsig: Internal Control Audit Report on Norske (Beijing) Pharmaceutical Technology Co., Ltd.
Norske: Independent Director Work System
Norsk: Rules of work for the Board Nomination Committee
Norsk: Announcement on the revision of the corporate governance system
Analysis
Price Target
No Data
